Publication | Closed Access

ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial

Il-15 SuperagonistMedicineImmunologyClinical TrialsImmune Checkpoint InhibitorCancer TreatmentImmunotherapyOncologyRadiation OncologyLung CancerHealth Sciences